Conventional Physical Therapy for Parkinson's (NCT07359716)
Improve balance through virtual reality
- Trial ID
- NCT07359716
- Official Title
- Virtual Reality Verses Conventional Physical Therapy in Parkinson's Disease Patients
- Goal
- Improve balance through virtual reality
- Phase
- NA
- Status
- COMPLETED
- Sponsor
- Montiha Azeem
- Study Type
- INTERVENTIONAL
- Enrollment
- 62 participants
- Conditions
- Parkinson s Disease
- Interventions
- Conventional Physical Therapy, Virtual Reality-Based Physical Therapy
Summary For Families
The trial is testing whether virtual reality physical therapy can improve balance, gait and everyday mobility in people with Parkinson's better than conventional physical therapy, with the goal of reducing falls and making walking and balance easier. The VR sessions use simulated environments and real-time visual feedback to guide balance and gait exercises and track progress, while the conventional arm uses standard strength, balance and walking training; VR is meant to boost engagement and deliver precise movement cues that complement usual medications like levodopa. Eligible participants are men and women aged 45 to 65 with Parkinson's and good cognition, MMSE 24 or higher; people with other neurologic diseases, recent lower limb fractures, recent major peripheral surgery or trauma, or spinal cord injury are excluded.
Locations
- Shadman Medical Center, Lahore, Pakistan
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Conventional Physical Therapy. The trial is testing whether virtual reality physical therapy can improve balance, gait and everyday mobility in people with Parkinson's better than conventional physical therapy, with the goal of reducing falls and making walking and balance easier. The VR sessions use simulated environments and real-time visual feedback to guide balance and gait exercises and track progress, while the conventional arm uses standard strength, balance and walking training; VR is meant to boost engagement and deliver precise movement cues that complement usual medications like levodopa. Eligible participants are men and women aged 45 to 65 with Parkinson's and good cognition, MMSE 24 or higher; people with other neurologic diseases, recent lower limb fractures, recent major peripheral surgery or trauma, or spinal cord injury are excluded.
- Who can participate?
- Participants must be between 45 Years and 65 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 2 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
- How many visits does this trial involve?
- You will have three treatment sessions per week for eight weeks, for a total of 24 sessions.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Surgical procedure (invasive). Confirm the full schedule with the study coordinator.